je.st
news
Tag: combinations
So Right Single-Serve Frozen Meals Available In 12 Flavor Combinations
2017-09-14 20:53:28| Food Processing
Bellisio Foods So Right line of single-serve frozen meals feature fresh-tasting, quality ingredients.
Tags: frozen
meals
combinations
flavor
PureCircle unveils new tool to provide stevia ingredient combinations
2017-09-14 01:00:00| Food Processing Technology
Malaysias stevia sweetener producer PureCircle has launched its new Sigma-Xcelerator product development tool to provide customised ingredient combinations.
Tags: provide
tool
combinations
ingredient
Wainbee offers air preparation solutions in many combinations
2016-02-11 10:32:43| Canadian Plastics Headlines
Parker’s Global FRL portfolio, available from Wainbee, features modular and versatile products that can be used in a variety of combinations. The post Wainbee offers air preparation solutions in many combinations appeared first on Canadian Plastics.
Tags: offers
air
solutions
preparation
Rexroth's GoPak(TM) Hydraulic Power Unit and GoDesigner(TM) Configuration Tool Offer Millions of Combinations with Quick Lead Times
2015-11-25 11:31:10| Industrial Newsroom - All News for Today
System allows engineers to streamline the design and ordering process with faster quotes and shorter lead times Bosch Rexroth GoPak hydraulic power units (HPU) bridge the gap between standard market products and engineered-to-order power units for machine tool, plastics, automotive, material handling, presses...
Merck Announces Initial Results for KEYTRUDA (pembrolizumab) with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress
2015-11-21 22:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. In Addition, Longer Term Follow-Up Single-Agent Data for KEYTRUDA Shows Continued Superior Overall Response Rate and Progression Free Survival Compared to Ipilimumab KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced findings from three studies investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in combination with three other immunotherapies epacadostat, IMLYGICTM (talimogene laherparepvec), and ipilimumab in patients with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orAn Phan, (908) 255-6325orInvestors:Teri Loxam, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
international
research
society